Abstract
Purpose
Choroideremia is a progressive X-linked recessive dystrophy, characterized by degeneration of the retinal pigment epithelium (RPE), choroid, choriocapillaris, and photoreceptors. We examined photoreceptor structure in a series of subjects with choroideremia with particular attention to areas bordering atrophic lesions.
Methods
Twelve males with clinically-diagnosed choroideremia and confirmed hemizygous mutations in the CHM gene were examined. High-resolution images of the retina were obtained using spectral domain optical coherence tomography (SD-OCT) and both confocal and non-confocal split-detector adaptive optics scanning light ophthalmoscope (AOSLO) techniques.
Results
Eleven CHM gene mutations (3 novel) were identified; three subjects had the same mutation and one subject had two mutations. SD-OCT findings included interdigitation zone (IZ) attenuation or loss in 10/12 subjects, often in areas with intact ellipsoid zones; RPE thinning in all subjects; interlaminar bridges in the imaged areas of 10/12 subjects; and outer retinal tubulations (ORTs) in 10/12 subjects. Only split-detector AOSLO could reliably resolve cones near lesion borders, and such cones were abnormally heterogeneous in morphology, diameter and density. On split-detector imaging, the cone mosaic terminated sharply at lesion borders in 5/5 cases examined. Split-detector imaging detected remnant cone inner segments within ORTs, which were generally contiguous with a central patch of preserved retina.
Conclusions
Early IZ dropout and RPE thinning on SD-OCT are consistent with previously published results. Evidence of remnant cone inner segments within ORTs and the continuity of the ORTs with preserved retina suggests that these may represent an intermediate state of retinal degeneration prior to complete atrophy. Taken together, these results supports a model of choroideremia in which the RPE degenerates before photoreceptors.
Introduction
Choroideremia is a progressive X-linked recessive dystrophy characterized by degeneration of the sensory retina[1] secondary to CHM gene mutations.[2, 3] Affected males typically experience nyctalopia and peripheral visual field loss by the second decade of life; central vision is usually affected later in the course of the disease.[4] Early peripheral pigmentary mottling of the fundus develops into choroidal and retinal atrophy, typically beginning in the midperiphery and expanding both centrally and peripherally.[5] Previous histological and optical coherence tomography (OCT) studies have led to various models of degeneration, including 1) a diffuse and independent degeneration of the choriocapillaris, retinal pigment epithelium (RPE), and neural retina,[6, 7] 2) a primary photoreceptor degeneration followed by RPE and choroidal atrophy,[6, 8] and 3) a primary RPE degeneration followed by photoreceptor loss and choroidal atrophy.[9–11] Additional OCT-documented characteristics of choroideremia include the presence of interlaminar bridges[8] (ILBs, wedge-shaped hyporeflective structures bridging the inner and the outer retina) and outer retinal tubulations[4, 12] (ORTs, structures in the outer retina composed of deteriorating photoreceptors and remnant external limiting membrane (ELM) that typically appear on OCT as hyperreflective ovaloid structures with a hyporeflective lumen[13]). Finally, Lazow et al report a relatively abrupt termination of the inner segment/outer segment ellipsoid zone (EZ) and ELM that frequently coincide with ILBs.[9, 14] While these studies highlight the utility of commercially-available SD-OCT in assessing the layered macroanatomy of the retina, their limited resolution precludes direct examination of photoreceptor structure on a cellular scale.
By correcting for the eye’s monochromatic aberrations, confocal adaptive optics scanning light ophthalmoscopy (AOSLO) enables cellular-resolution imaging of photoreceptor structure,[15, 16] and numerous studies have used AOSLO to probe the fine anatomy of retinal degenerations.[12, 17–26] Indeed, confocal AOSLO has recently been used to document lack of cone reflectivity in the ORTS found in age-related macular degeneration.[27] In choroideremia, AOSLO imaging has uncovered novel pathologic features including bubble-like lesions that appear to co-localize to structures in the choroid visualized by SD-OCT[26] and yielded results suggesting a primary RPE degeneration with subsequent loss of photoreceptors and choroid.[12, 26] Recent work by Morgan et al showed an abrupt decline in confocal AOSLO photoreceptor reflectivity in areas of RPE degeneration[26], while SD-OCT imaging revealed interdigitation zone (IZ, thought to represent the junction of photoreceptors and RPE) dropout and RPE thinning prior to disruptions in the overlying EZ.[26] Together, these results may imply cone loss in choroideremia is secondary to the atrophy of supporting RPE. However, imaging of cone structure with confocal AOSLO imaging relies upon propagation and reflectance of the incident imaging light within an intact and properly aligned outer segment (i.e., waveguiding).[28] Disruptions of cone morphology in choroideremia[6, 7] might therefore interfere with confocal imaging of cones, making it impossible to distinguish a non-waveguiding cone from an absent one. Thus, within the context of choroideremia, it remains unknown whether the photoreceptor mosaic truly terminates at the point of RPE atrophy.
In contrast, the signal in split-detector AOSLO originates from multiply-scattered light from the inner segment,[28] thus decoupling cone visualization from outer segment morphology. Split-detector AOSLO has been used to provide unambiguous characterization of remnant cone morphology in a number of retinal diseases.[28–33] Here, we used split-detector AOSLO in conjunction with confocal AOSLO and SD-OCT to assess outer retinal structure in choroideremia. We examined areas bordering regions of atrophy and within characteristic ORTs, ILBs, and bubble-like lesions with the aim of clarifying the sequence of degeneration, which may in turn assist the development of therapeutic strategies.[34, 35]
Methods
Subjects
Research procedures were in accordance with the tenets of the Declaration of Helsinki and were approved by the Institutional Review Boards of the Medical College of Wisconsin and the Children’s Hospital of Wisconsin. After explanation of the nature and possible consequences of the study, informed written consent was obtained from all subjects. Subjects with clinically-diagnosed choroideremia were eligible for inclusion. Between August 2010 and June 2014, 12 male subjects were enrolled in the study and imaged (Table 1); several subjects were followed across more than one imaging session, and the most recent follow-up imaging was performed in January 2016. For comparison, we utilized images from a healthy subject (28-year-old male, JC_0616) as well as previously-published cone density data from nine healthy subjects.[36]
Table 1. Characteristics of 12 Male Subjects with Choroideremia.
Subject | Age | Identified CHM Gene Mutations | Genetic References | Eye | Near-Foveal Cones/mm2 ‡ | Central RT | Average RT | BLLs | ILBs | ORTs |
---|---|---|---|---|---|---|---|---|---|---|
KS_0044 | 19 | Deletion of exons 6, 7, and 8 | Freund PR et al, Mol Genet Genomic Med 2016 | OD | 87,603 | 99% (+) | Normal | Yes | Yes | Yes |
JC_0618* | 46 | c.757C>T; p.Arg253Stop | Van den Hurk JA et al, Hum Genet 2003 | OD | N/A§ | Normal | Normal | Yes | Yes | Yes |
JC_0621 | 64 | Deletion of exon 15 | Novel exon deletion | OS | 67,886 | Normal | Normal | No | Yes | Yes |
JC_0672 | 55 | Partial deletion of exon 4 c.314+10127T>A splice site mutation | McTaggart et al, Hum Mutat 2002 Van den Hurk JA et al, Hum Genet 2003 | OD | N/A§ | Normal | 99% (-) | Yes | Yes | Yes |
JC_0675 | 56 | c.190-2A>G splice site mutation | Van den Hurk JA et al, Hum Genet 2003 | OS | N/A§ | 99% (-) | 99% (-) | Yes | Yes | Yes |
JC_0699 | 72 | c.1349G>A; p.Arg450Lys | Reported to the Vision Variation Database[37] | OD | N/A§ | Normal | Normal | Yes | No | Yes |
JC_0752 | 29 | c.1530_1531insA fs*4; p.Thr511Asn fs*4 | Novel frameshift with truncation | OD | N/A§ | Normal | Normal | Yes | Yes | Yes |
JC_0754 | 40 | c.1579_1582delTTGT; p.Leu527His fs*7 | Novel frameshift with truncation | OD | 71,890 | 99% (+) | Normal | Yes | Yes | Yes |
JC_0778† | 22 | c.757C>T; p.Arg253Stop | Van den Hurk JA et al, Hum Genet 2003 | OD | 95,771 | 95% (+) | Normal | Yes | Yes | Yes |
JC_0782† | 25 | c.757C>T; p.Arg253Stop | Van den Hurk JA et al, Hum Genet 2003 | OD | 76,551 | Normal | Normal | No | No | No |
JC_0942 | 40 | c.1144G>T; p.Glu282Stop | Reported to the Leiden Open Variation Database[38] | OD | N/A§ | 95% (+) | Normal | Yes | Yes | Yes |
DW_10173 | 40 | Deletion of exons 1–15 (complete deletion) | Den Dunnen and Antonarakis, Hum Genet 2001 | OS | N/A§ | Normal | 95% (-) | Yes | Yes | Yes |
Eye = eye used for all measurements, assessments, imaging, and analysis. Central RT = central retinal thickness as a percentile of normal. Average RT = average retinal thickness as a percentile of normal. BLLs = bubble-like lesions. ILBs = interlaminar bridges. ORTs = outer retinal tubulations. Fs = frameshift. Del = deletion. Ins = insertion. Stop = stop codon (truncation). *(n) = stop codon in n residues.
* Unrelated to JC_0778 and JC_0782.
† First cousins. JC_0782 independently sought genetic testing and presented results at time of study.
‡ Cone densities were measured at 0.70° (202.5 μm) eccentricity. Normal mean cone density at this eccentricity is 76,038 cones/mm2 (SD 31,543 cones/mm2).
§ In subjects with no EZ band visible at the fovea on SD-OCT due to advanced pathology, no near-foveal cone count was measured.
Genetic Testing and Predictions
Whole blood was collected for analysis from 11 out of 12 subjects; the 12th subject had previously obtained genetic testing. Eight samples were sent to The John and Marcia Carver Nonprofit Genetic Testing Laboratory (University of Iowa, IA, USA), two to the National Ophthalmic Disease Genotyping and Phenotyping Network (EyeGENE, National Eye Institute, Bethesda, MD, USA), and one to the Casey Eye Institute Molecular Diagnostics Laboratory (Oregon Health & Science University, OR, USA). Each sample was screened for mutations in the CHM gene. For the remaining subject, genetic records were available from the referring physician (The Chicago Lighthouse, Chicago, IL, USA). Amino acid changes due to novel gene mutations were determined using Mutation Taster (available in the public domain at http://www.mutationtaster.org).
Clinical Examination
Dilated fundus exams were performed prior to imaging. Axial length measurements were obtained using an IOL Master (Carl Zeiss Meditec, Dublin, CA USA) and used to calibrate the lateral scale of all retinal images (see Methods). For all imaging sessions, one eye of each subject (OD in all except JC_0675 and DW_10173) was dilated and accommodation suspended using one drop each of phenylephrine (2.5%) and tropicamide (1%). Color fundus images were obtained in all subjects using a Zeiss VisuCam 200NM (Carl Zeiss Meditec, Dublin, CA, USA) and/or an OPTOS Ultra-Widefield fundus camera (Optos plc, Dunfermline, Scotland, United Kingdom). Fundus images were exported using onboard software for subsequent alignment with high-resolution images.
Spectral Domain Optical Coherence Tomography (SD-OCT)
Volumetric images of the macula were obtained using optical coherence tomography (Cirrus HD-OCT; Carl Zeiss Meditec, Dublin, CA, USA). Volumes were nominally 6 x 6 mm and consisted of 128 B-scans (512 A-scans/B-scan). Retinal thickness was calculated using the built-in macular analysis software (version 5.0) as the distance between inner limiting membrane (ILM) and RPE boundaries. Additional high-density volume scans of the macula were acquired (Envisu 2300; Bioptigen, Research Triangle Park, NC, USA); scans were nominally 6 x 6 mm or 7 x 7 mm in size and consisted of 250 B-scans (700 A-scans/B-scan). High-density line scans (nominal scan length = 6 or 7 mm; 1000 A-scans/B-scan, 100 to 120 repeated B-scans) were acquired both horizontally and vertically through the foveal center. Line scans were registered and averaged to reduce image speckle as previously described.[39] In a few cases, 3 to 4 closely spaced B-scans within a volume were averaged to generate higher signal to noise images at non-foveal regions of interest (ROIs). Assessment of layer integrity at specific locations was performed using the longitudinal reflectivity profile (LRP), as previously described.[40, 41] Four layers were manually identified in the resultant LRPs: the external limiting membrane, ELM; the EZ; the IZ; and the retinal pigment epithelium, RPE.
Using custom designed Java (Oracle, Redwood City, CA) software, we derived en face summed volume projection (SVP) images from the Bioptigen SD-OCT volumes of 8 subjects using a previously described method.[31, 42] These images were created to visualize the two-dimensional layout of ORTs.
Adaptive Optics Scanning Light Ophthalmoscopy
Reflectance confocal images of the photoreceptor mosaic were obtained using a previously described AOSLO.[15, 43, 44] Retinal images were obtained using 775, 790, or 796 nm superluminescent diodes, subtending 1, 1.5, or 1.75° square fields of view. In 5 subjects (KS_0044, JC_0699, JC_0778, JC_0782, DW_10173), split-detector AOSLO images were captured simultaneously with confocal ones (and thus are in perfect spatial co-register). Foveal images were acquired by instructing the patient to fixate on the corners or edges of the imaging raster (eccentricities of 0.5 or 0.65°), while parafoveal images were acquired using an adjustable external fixation target extending out to eccentricities of up to 12°. Additional images were acquired as needed to assess specific ROIs.
Raw AOSLO retinal images were corrected for distortions, registered, and averaged as previously described.[32, 45] These registered and averaged AOSLO images were manually montaged using Adobe Photoshop (Adobe Systems, Inc., CA) as previously described.[32] Line scanning ophthalmoscope (LSO) images from the Cirrus HD-OCT and volume intensity projection images from the Bioptigen SD-OCT were exported and, together with AOSLO montages, aligned to the clinical fundus images. The relative sizes of multimodal images were derived by scaling the visual angle for an ideal eye with an axial length of 24 mm, 291 μm/degree, in proportion to the subject’s measured axial length.[46] Alignment was performed manually utilizing blood vessel patterns. This multimodal aligned overlay enabled comparison of retinal structure at specific ROIs.
For clarity, areas of retina (typically central) with discernible IZ and/or EZ structure will henceforth be referred to as “preserved retina,” while areas of retina (typically peripheral) with neither IZ nor EZ structure is referred to as “atrophic retina.” Regions of abnormal preserved retina that border atrophic lesions (generally within a few hundred microns) are referred to as “border regions.”
Parafoveal Cone Density Measurements and Statistical Analysis
In 5 subjects (KS_0044, JC_0621, JC_0754, JC_0778, and JC_0782) in whom OCT B-scans showed an intact EZ at the fovea, near-foveal cone densities were counted from AOSLO confocal images acquired on the same day as the OCT scans shown in Fig 1. Please note that despite overlap (KS_0044, JC_0778, and JC_0782), these are not the same five subjects for which AOSLO split detector imaging was obtained. Although JC_0752 had an intact EZ at the fovea, poor foveal image quality precluded cone counting. The anatomic fovea can sometimes be difficult to resolve due to extremely tight cone packing. Ability to visualize cones may also be locally or globally compromised on AOSLO despite high-quality OCT imaging, particularly in subjects with poor fixation, severe visual impairment, advanced age, and/or other media-opacifying intraocular processes (e.g. cataracts). ROIs used in cone counts were generated by manually cropping 50 x 50 μm square sampling areas at an average of 0.70° (approximately 202.5 μm) eccentricity. Cones were frequently not countable at the true anatomic foveal pit because such cones were too tightly packed to be resolvable on AOSLO.
Cones were identified from confocal AOSLO images using a previously-described custom semi-automated algorithm that locates cones based on local intensity maxima, followed by manual adjustments by a single observer (L.W.S.).[47] Image contrast was adjusted as needed to assist in manually identifying dimly reflective cones. Density (in cones/mm2) was calculated by dividing the number of counted cones by the summed area (in mm2) of the bound Voronoi domains in the ROI,[48] and compared to an exponential fit to normative cone density data from 9 healthy subjects developed by Wilk et al.[36] T-scores were calculated using Student’s t-test for two independent means, and corresponding two-tailed p-values were generated using t-scores and degrees of freedom calculated as independent samples (QuickCalcs, GraphPad Software, Inc., La Jolla, CA).
Cone Density and Diameter Measurements in Areas Bordering Lesions
Lesion borders were mapped using OCT en face imaging and projected onto confocal AOSLO images using the aforementioned registration methods. In subjects with split-detector AOSLO imaging, lesion borders were mapped using split-detection. Cone density near the borders of lesions was also measured using the split-detector AOSLO images because confocal AOSLO was unable to unambiguously identify all cones due to irregular reflectivity in pathologic areas. Paired 50 x 50 μm ROIs were cropped from each AOSLO montage of the 5 subjects with both split-detector and confocal imaging. ROI pairs were chosen such that each was within 200 μm of the nearest lesion border, and both were at approximately the same eccentricity from the foveal pit. One ROI was cropped from an area of visibly higher cone density and one was cropped from an area of visibly lower cone density. No semiautomated algorithm was available at the time of these experiments, so all cones were manually identified within each ROI by a single observer (L.W.S.). Because ROIs varied in eccentricity based on individual pathology, it was not possible to conduct formal statistical analyses on the data. However, comparisons to normal cone densities from the previously-referenced database of nine healthy subjects[36] were performed by using an exponential fit to normative cone density data to calculate expected differences in cone density at each of the pairs of ROIs sampled.
Results
Subject Demographics, Clinical Data, and Genetics
Subject demographics, genetic profiles, and a brief summary of OCT and AOSLO findings are given in Table 1. Twelve males (mean ± SD age = 44.6 ±16.5 years) with choroideremia were recruited based on clinical diagnoses of choroideremia, which took into account personal ocular history, presenting symptoms, and family history. Disease was confirmed by genetic analysis in 11 of 12 cases; in the 12th case, JC_0782, the subject had obtained genetic testing through his referring physician prior to our study. This patient is also the first cousin of JC_0778, who was among the 11 patients for whom we requested genetic testing.
We identified a total of 11 mutations within the 12 subjects (Table 1), 8 of which had been previously reported. Two previously documented[49, 50] mutations, a splice site mutation and a partial deletion, were found in subject JC_0672. Three subjects were found to have the same previously published point mutation resulting in truncation, c.757C>T (p.Arg253Stop);[50] two of these subjects were first cousins (JC_0778 and JC_0782), but the third (JC_0618) was unrelated. Five other previously-reported mutations were found in our subjects: one complete CHM gene deletion, two deletions of one or more exons of the CHM gene, one single base pair substitution resulting in truncation, and one splice site mutation. To the best of our knowledge, the remaining 3 mutations were novel: a deletion of most or all of exon 15 (JC_0621) and two frameshift mutations (JC_0752 and JC_0754, both with truncation occurring shortly after frameshift). Because all novel mutations found in our subjects were deletions or frameshifts, the commonly-used tools SIFT, PROVEAN (both available in the public domain at http://provean.jcvi.org/index.php), and/or PolyPhen-2 2.2.2 (available in the public domain at http://genetics.bwh.harvard.edu/pph2) could not be used to assess probable pathogenicity.
Pathologic Features Visualized with SD-OCT
Fig 1 shows averaged horizontal line scans through the anatomic foveal pit of all subjects, and S1 Fig shows corresponding averaged vertical line scans also through the fovea. Upon examination of all horizontal and vertical line scans, the IZ band is absent and/or indistinct from the RPE band in all but two subjects even in areas where the outer retinal layers were otherwise visible, which is consistent with previous reports in choroideremia.[26] The exceptions were JC_0782 and KS_0044, both young subjects followed for extensive periods (JC_0782: age 21 at initial imaging, followed over 47 months; KS_0044: age 16 at initial imaging, followed over 36 months). In both cases, an intact and distinct IZ band was initially seen centrally with peripheral loss of IZ band discrimination. While JC_0782 has exhibited slow disease progression limited to the periphery, KS_0044 has progressed more rapidly with patchy IZ band loss first noted centrally at age 17 (6 months after initial visit) and near-complete loss of IZ band discrimination in both eyes at his latest visit (age 19). Repeat SD-OCTs taken at 3 different time points in 3 subjects (KS_0044, JC_0778, and JC_0782) are representative of the peripheral-to-central progression of the disease observed in the 7 subjects (KS_0044, JC_0618, JC_0621, JC_0699, JC_0752, JC_0778, and JC_0782) who were imaged across at least two visits.
In all subjects, areas of thinned RPE band were also noted in the periphery, and sometimes in the fovea. In general, RPE thinning is associated with notable overlying abnormalities of the IZ and EZ bands. Finally, loss of the EZ band was also noted peripherally in all subjects except JC_0782, who exhibited patchy EZ band attenuation at the far periphery of the 7 mm area examined by SD-OCT line scan. In 10/12 cases, both the EZ band and overlying ELM were noted to terminate sharply at an ILB in at least one hemiretina, again consistent with previous reports.[9]
Other previously reported SD-OCT features were also seen in our subjects, including relative retention of retinal lamination at and around the fovea, chorioretinal atrophy in the periphery, ORTs, and ILBs. Changes in retinal thickness were also observed, including central thickening in 4 patients (aged 19, 22, 40 and 40 years) and general thinning in 3 patients (aged 40, 55, and 56 years). Table 1 summarizes these pathologic SD-OCT findings. Note, not all findings are evident in the horizontal and vertical line scans through the fovea; some are visible only in volume scans through the 7 mm foveal area.
Parafoveal Cone Density Measurements using Confocal AOSLO
Within our cohort of 12 subjects, cone densities were measured at or near the anatomic foveal pit in 5 subjects. Cone densities were only obtained from subjects with OCT B-scans showing intact EZs at the fovea. This is because only confocal imaging could resolve foveal cones, and only reflectivity in areas with intact EZs could be confidently regarded as cone reflectivity could be used for cone density measurements. Consequently, cone densities were only measured in subjects with comparatively mild pathology. Confocal AOSLO images acquired on the same day as the OCT B-scans shown in Fig 1 were used in near-foveal cone density measurements. Sampling windows for these 5 subjects are shown in S2 Fig. The average eccentricity of the 5 near-foveal cone density measurements was 202.5 μm, or approximately 0.70°. The mean (±SD) near-foveal cone density was 79,940 ± 11,521 cones/mm2 (Table 1), which did not differ significantly (two-tailed p = 0.79) from the normal mean (±SD) near-foveal cone density at 202.5 μm eccentricity, 76,038 ± 31,542.75 cones/mm2.[36]
Disambiguation of Remnant Cone Structure with Split-Detector AOSLO
Fig 2 shows a comparison of confocal and split-detector AOSLO images in all 5 subjects imaged with both modalities and one healthy control subject. The split-detector modality provides unambiguous visualization of cone inner segments in areas of preserved retina and near lesion borders. While increased scleral shine-through on confocal AOSLO imaging can be used to approximate lesion borders, split-detector imaging can more precisely identify and localize lesion borders as sharply-circumscribed perimeters where photoreceptor inner segment mosaics terminate. Furthermore, confocal AOSLO cannot be used to reliably identify cones in far-peripheral or pathologic areas due to irregularities in confocal reflectivity, where some cones appear as clusters of bright spots not easily distinguishable from rod or RPE reflectivity. In contrast, split-detector AOSLO unambiguously resolves cone inner segments even in the very peripheral and/or diseased areas, enabling observation of pathologic cone density, size, and morphology.
Sharp Transitions Observed Between Areas with Remnant Cone Mosaic and Areas of Atrophy
We observed variable photoreceptor density, spacing and morphology near lesion borders and abrupt delineations between areas with a remnant cone mosaic and areas of atrophy. This does not seem to be the case in other retinal dystrophies such as retinitis pigmentosa (RP), in which the transition between preserved and atrophic retina occurs over an extended transition zone several hundreds or thousands of microns wide.[32] Fig 3 contrasts SD-OCT and AOSLO retinal imaging in a representative subject (JC_0778) with choroideremia with previously-published[32] SD-OCT and AOSLO images from a subject (DH_10161) with RP. Although DH_10161 demonstrates a classic pattern of peripheral-to-central degeneration, it should be emphasized that RP is an extremely diverse family of diseases with equally broad-ranging findings that cannot be fully encompassed by a single subject.
In 4 of the 5 choroideremia subjects for whom both confocal and split-detector imaging were available, outer segment reflectivity (seen on confocal AOSLO) and inner segment structure (seen on split-detector AOSLO) were simultaneously extinguished at lesion borders. The cone inner segment mosaic in areas of preserved retina formed a largely continuous and closely packed mosaic up to the edge of the lesion, but was observed to abruptly terminate at the point of EZ dropout (Fig 3C). This point of EZ dropout and inner segment disappearance also coincided with ELM dropout in these 4 cases, and with an interlaminar bridge (ILB) in at least one direction in these 4 cases, consistent with reports by Lazow et al.[9] In the 5th case, the cone mosaic termination point was beyond the SD-OCT scan volume.
Foveal cone reflectivity was relatively normal in subjects with choroideremia (Fig 3A1), which differed from the numerous non-waveguiding cones visible in subjects with RP even in areas of intact IZ (Fig 3E1).[32] In both choroideremia and RP, the inner segment mosaic remains densely and regularly packed in pre-IZ dropout areas. Finally, in both conditions, the cone mosaic exhibits dimmer and altered confocal reflectivity after IZ band dropout on SD-OCT, but appears largely normal on split-detector AOSLO (Fig 3B).
Heterogeneous Photoreceptors and Photoreceptor Mosaics at Lesion Borders
Cone density in approximately equally-eccentric areas of remnant retina near the edges of atrophic lesions was observed to vary significantly in all 5 subjects imaged with split-detector AOSLO (Fig 4). To sample this variability, paired cone-counting ROIs in areas of high and low density were manually selected in each montage. Split-detector images were used, as cone densities could not be reliably measured near lesion borders using confocal AOSLO. The mean eccentricity difference between sampling ROIs for high- vs. low-density areas of the mosaic was 186 μm (maximum eccentricity difference = 395 μm), and ROIs were cropped within 200 μm of the nearest lesion border. Complete results are presented in Table 2.
Table 2. Cone Density Variability Near Lesion Borders.
Subject | Dense Region | Sparse Region | Expected Density Difference | Measured Density Difference | Mean Normal Data | ||||
---|---|---|---|---|---|---|---|---|---|
Density (Cones/mm2) | Eccentricity (mm) | Density (Cones/mm2) | Eccentricity (mm) | Mean Density (Cones/mm2) | Standard Deviation | Eccentricity (mm) | |||
KS_0044 | 15,474* | 2.362 | 8,049† | 1.967 | -1,636 | 7,425‡ | 11,833 | 1,816 | 2.142 |
JC_0699 | 17,960 | 1.725 | 9,937 | 1.658 | -383 | 8,023‡ | 14,122 | 2,098 | 1.694 |
JC_0778 | 5,917 | 3.256 | 5,276 | 3.529 | 712 | 641 | 7,305§ | 1,506§ | 3.455§ |
JC_0782 | 15,062* | 3.684 | 10,458* | 3.646 | -91 | 4,604‡ | |||
DW_10173 | 16,857 | 1.222 | 10,152† | 1.066 | -2,034 | 6,705‡ | 19,966 | 3,226 | 1.127 |
Expected density difference = (mean normal cone density at eccentricity of dense region in choroideremic patient)–(mean normal cone density at eccentricity of sparse region in choroideremic patient). Negative value indicates the region with denser cones was actually expected to have sparse cones due to greater eccentricity from the fovea.
* Cone density is >2 SD greater than normal mean cone density at a comparable eccentricity.
† Cone density is >2 standard deviations (SD) less than normal mean cone density at a comparable eccentricity.
‡ Cone density difference is >2 SD of normal mean cone density at a comparable eccentricity.
§ The same measured normal data was used in comparison to data from both JC_0778 and JC_0782 because of similar eccentricities of measurements.
In one case (JC_0778), the measured difference in cone density was similar to the expected calculated normal density difference due to change in eccentricity (see Methods). In the remaining 4 cases, measured density differences deviated greatly from expected density differences. Furthermore, in all subjects except JC_0778, cone density variability between paired ROIs exceeded 2 SD of the mean cone density measured from 9 normal subjects.[36] The mean difference in eccentricity between normal and choroideremia sampling areas was 63 μm (maximum eccentricity difference = 210 μm). Interestingly, cone densities could be either significantly greater than (JC_0782) or less than (DW_10173) normal. One subject, KS_0044, had cone densities both statistically significantly greater and lower than normal.
Axial Localization of Bubble-like Lesions
Bubble-like lesions were frequently observed on confocal AOSLO in the atrophic retina near lesion borders. Previous reports have proposed that these lesions may correspond to subretinal structures seen on SD-OCT.[26] Findings in our subjects concur with this observation. After SD-OCT images were precisely scaled, aligned, and mapped to confocal AOSLO montages, nearby objects of interest (e.g. retinal tubulations, pigment clumps, and blood vessels) were used to assist localization of bubble-like lesions to the approximate areas labeled by black arrowheads on SD-OCT (Fig 5).
Remnant Cone Structure within Interconnected Outer Retinal Tubulations (ORTs)
Outer retinal tubulations (ORTs) were observed in 10 of 12 subjects on SD-OCT. Fig 6 shows representative en face SD-OCT images alongside averaged horizontal and vertical line scans through the fovea. Consistent with previous reports,[13, 14, 30] ORTs typically appear on SD-OCT as ovaloid hyperreflective structures with hyporeflective lumens located between the RPE and the outer nuclear layer. IZ and EZ bands were not discernible within ORTs. The axially elongated shape of ORTs is an artifact of SD-OCT aspect ratio, which is typically chosen to provide higher axial vs. lateral magnification. Histology has shown that ORTs are more frequently axially flattened ovaloids.[14] Viewed en face, these ORTs can be clearly seen as long, thin protrusions that are mostly interconnected and contiguous with central preserved retina. Some “island” ORTs were observed, which may have detached from nearby ORTs through progressive degeneration (Fig 6).
By precisely aligning SD-OCT B-scans, SD-OCT en face projections, and AOSLO confocal and split detector images, direct comparison of the anatomy of preserved retina and ORTs across different imaging modalities was possible. Of the 5 subjects imaged with split-detector AOSLO, 4 displayed ORTs (JC_0782 had relatively mild disease and no ORTs were visualized). Fig 7 shows an example comparison of the same ORT and an immediately adjacent area of remnant retina across multiple imaging modalities. SD-OCT imaging reveals that the infolded ORT is morphologically distinct from the nearby, wider ORT-like region of preserved retina, in which the typical retinal architecture is attenuated but partially retained.
In the split-detector images, large, sparse, remnant cone inner segments were clearly observed within ORTs of all subjects. Panels 7D2-G2 show split-detector AOSLO images of representative ORTs from these 4 subjects. Cone inner segments of relatively normal diameter, density and orientation are also seen in adjacent areas of preserved retina. The split-detector imaging wide-field montage of the border of an area of atrophy in KS_0044 (Fig 7C) reveals most of the salient features discussed in preceding sections, including abnormal cone mosaics, ORTs, and bubble lesions.
Discussion
The recently-developed split-detector AOSLO imaging modality allows unambiguous imaging of cone photoreceptor inner segments even in the setting of pathologies that disrupt waveguiding.[28–33] This circumvents an inherent drawback of previous AO imaging modalities in which photoreceptor visualization was dependent on the waveguided reflectance of imaging light through an intact cone outer segment.[28]
Using split-detector AOSLO imaging, we examined the photoreceptor mosaic in subjects with choroideremia and uncovered several novel findings. Foveal cone densities were normal in subjects with preserved EZ bands on SD-OCT, though it should be noted that disease progression was relatively mild in these patients. The cone mosaic was contiguous throughout regions of preserved retina; however, cone densities in areas near lesion borders could be significantly increased or decreased from normal, and individual cone inner segments appeared dysmorphic and enlarged. The loss of cone reflectivity on confocal AOSLO at lesion borders (previously reported by Morgan et al.[26]) was found to colocalize with a complete loss of the remnant cone inner segment mosaic and with ILBs. This sharp termination of the cone inner segment mosaic at well-delineated lesion borders, combined with early IZ band abnormalities and RPE band thinning on SD-OCT,[26] reinforces the theory that cone loss is predicated on underlying RPE degeneration, and may offer additional evidence toward a primary RPE degeneration model of choroideremia.[6, 8, 12, 26]
The macro- and microanatomy of ORTs was also examined. Zweifel et al.[13] first reported these characteristic structures in OCT images acquired from subjects with age-related macular degeneration,[13] while recent work by Litts et al. revealed that the branching, interconnected structure of ORTs is composed of degenerating cones and infolded ELM.[14] Consistent with recent results published by Litts et al.,[27] ORTs did not display IZ/EZ bands on SD-OCT or recognizable cone reflectivity on confocal imaging. However, we did observe remnant cone inner segments in these structures using split-detector imaging. These cones appeared enlarged and morphologically irregular, suggesting a state of advanced degeneration. Interestingly, this association of remnant inner segments to preserved ELM is also seen in the transition zone of retinitis pigmentosa. However, in choroideremia, the ELM typically terminates too close to EZ dropout to definitively associate its presence with inner segment visibility.[32] Our data also confirms that although noncontiguous ORT “islands” could be seen near ORT tips, ORTs are generally contiguous with one another and with the central region of preserved retina. As was previously proposed,[13] ORTs appeared to degenerate slowly, persisting relatively unchanged over several months or years of follow-up imaging. Together, these findings suggest that ORTs are an end stage of retinal degeneration.
Finally, we endeavored to localize the “bubble-like” lesions previously noted by Morgan et al.[26] These lesions were best seen on confocal AOSLO, and by precisely aligning these images with SD-OCT of the same area, these lesions were mapped to choroidal sources on SD-OCT. However, it should be emphasized that the exact source of these bubble-like lesions has yet to be determined, owing both to a relatively large depth of field on AOSLO and limited resolution on SD-OCT. Furthermore, these structures cannot be readily identified by SD-OCT alone at this point, as they are not easily distinguished from other structures in the choroid (e.g., blood vessels). Although more work is needed to characterize the pathophysiology of these lesions, bubble-like lesions were most frequently seen in areas near the leading edge of atrophic lesions, possibly suggesting a link to recent or active atrophy.
This study illustrates some of the benefits of a multimodal imaging approach combining SD-OCT with confocal and split-detector AOSLO in studying retinal degenerations, and contributes to a growing body of literature concerning the pathophysiology and progression of choroideremia. In the future, we expect additional studies using these modalities, as well as emerging techniques including AO microperimetry,[51] OCT-angiography and directional OCT,[52] will provide further insight into choroideremia and other retinal degenerations. In addition, these non-invasive, in vivo high-resolution imaging modalities may aid in the selection of eligible subjects for novel gene therapy trials[34] and offer improved monitoring of disease progression.
Supporting Information
Acknowledgments
The authors are grateful to Robert F. Cooper and Alexander Salmon for the development of software functionalities used in data analysis; to Melissa Wilk for numerous helpful discussions; and to Brian Higgins, Christopher Langlo, Erika Phillips, Jungtae Rha, and Fouad Zakka for their contributions to the collection and processing of data.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under Award Numbers P30EY001931 & R01EY017607. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support comes from the Richard O. Schultz, MD / Ruth Works Professorship, The Edward N. & Della L. Thome Memorial Foundation, Foundation Fighting Blindness, the Thomas M. Aaberg Sr. Retina Research Fund, the Gene and Ruth Posner Foundation, and the R.D. and Linda Peters Foundation. This investigation was conducted in part in a facility constructed with support from the Research Facilities Improvement Program; grant number C06RR016511 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Sorsby A, Franceschetti A, Joseph R, Davey JB. Choroideremia; clinical and genetic aspects. Br J Ophthalmol. 1952;36(10):547–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Cremers FP, van de pol D, van kerkhoff L, wieringa B, Ropers H. Cloning of a gene that is rearranged in patients with choroideraemia. Nature. 1990;347:674–7. 10.1038/347674a0 [DOI] [PubMed] [Google Scholar]
- 3.van Bokhoven H, van den Hurk JA, Bogerd L, Philippe C, Gilgenkrantz S, de Jong P, et al. Cloning and characterization of the human choroideremia gene. Hum Mol Genet. 1994;3(7):1041–6. [DOI] [PubMed] [Google Scholar]
- 4.Heon E, Alabduljalil T, Iii DB, Cideciyan AV, Li S, Chen S, et al. Visual function and central retinal structure in choroideremia. Invest Ophthalmol Vis Sci. 2016;57(9):OCT377–87. 10.1167/iovs.15-18421 [DOI] [PubMed] [Google Scholar]
- 5.Coussa RG, Traboulsi EI. Choroideremia: a review of general findings and pathogenesis. Ophthalmic Genet. 2012;33(2):57–65. 10.3109/13816810.2011.620056 [DOI] [PubMed] [Google Scholar]
- 6.Syed N, Smith JE, John SK, Seabra MC, Aguirre GD, Milam AH. Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia. Ophthalmology. 2001;108(4):711–20. [DOI] [PubMed] [Google Scholar]
- 7.MacDonald IM, Russell L, Chan CC. Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol. 2009;54(3):401–7. 10.1016/j.survophthal.2009.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jacobson SG, Cideciyan AV, Sumaroka A, Aleman TS, Schwartz SB, Windsor EA, et al. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci. 2006;47(9):4113–20. 10.1167/iovs.06-0424 [DOI] [PubMed] [Google Scholar]
- 9.Lazow MA, Hood DC, Ramachandran R, Burke TR, Wang YZ, Greenstein VC, et al. Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP). Invest Ophthalmol Vis Sci. 2011;52(13):9581–90. 10.1167/iovs.11-8554 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Flannery JG, Bird AC, Farber DB, Weleber RG, Bok D. A histopathologic study of a choroideremia carrier. Invest Ophthalmol Vis Sci. 1990;31(2):229–36. [PubMed] [Google Scholar]
- 11.Rodrigues MM, Ballintine EJ, Wiggert BN, Lee L, Fletcher RT, Chader GJ. Choroideremia: a clinical, electron microscopic, and biochemical report. Ophthalmology. 1984;91(7):873–83. [PubMed] [Google Scholar]
- 12.Syed R, Sundquist SM, Ratnam K, Zayit-Soudry S, Zhang Y, Crawford JB, et al. High-resolution images of retinal structure in patients with choroideremia. Invest Ophthalmol Vis Sci. 2013;54(2):950–61. 10.1167/iovs.12-10707 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zweifel SA, Engelbert M, Laud K, Margolis R, Spaide RF, Freund KB. Outer retinal tubulation: A novel optical coherence tomography finding. Arch Ophthalmol. 2009;127(12):1596–602. 10.1001/archophthalmol.2009.326 [DOI] [PubMed] [Google Scholar]
- 14.Litts KM, Ach T, Hammack KM, Sloan KR, Zhang Y, Freund KB, et al. Quantitative analysis of outer retinal tubulation in age-related macular degeneration from spectral-domain optical coherence tomography and histology. Invest Ophthalmol Vis Sci. 2016;57(6):2647–56. 10.1167/iovs.16-19262 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dubra A, Sulai Y, Norris JL, Cooper RF, Dubis AM, Williams DR, et al. Noninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope. Biomed Opt Express. 2011;2(7):1864–76. 10.1364/BOE.2.001864 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Rossi EA, Chung M, Dubra A, Hunter JJ, Merigan WH, Williams DR. Imaging retinal mosaics in the living eye. Eye. 2011;25(3):301–8. 10.1038/eye.2010.221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Duncan JL, Zhang Y, Gandhi J, Nakanishi C, Othman M, Branham KEH, et al. High-resolution imaging with adaptive optics in patients with inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2007;48(7):3283–91. 10.1167/iovs.06-1422 [DOI] [PubMed] [Google Scholar]
- 18.Carroll J, Baraas RC, Wagner-Schuman M, Rha J, Siebe CA, Sloan C, et al. Cone photoreceptor mosaic disruption associated with Cys203Arg mutation in the M-cone opsin. Proc Natl Acad Sci USA. 2009;106(49):20948–53. 10.1073/pnas.0910128106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Godara P, Rha J, Tait DM, McAllister J, Dubis A, Carroll J, et al. Unusual adaptive optics findings in a patient with bilateral maculopathy. Arch Ophthalmol. 2010;128(2):253–4. 10.1001/archophthalmol.2009.383 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Duncan JL, Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Day S, et al. Cone structure in retinal degeneration associated with mutations in the peripherin/RDS gene. Invest Ophthalmol Vis Sci. 2011;52(3):1557–66. 10.1167/iovs.10-6549 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Michaelides M, Rha J, Dees EW, Baraas RC, Wagner-Schuman ML, Mollon JD, et al. Integrity of the cone photoreceptor mosaic in oligocone trichromacy. Invest Ophthalmol Vis Sci. 2011;52(7):4757–64. 10.1167/iovs.10-6659 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Talcott KE, Ratnam K, Sundquist S, Lucero AS, Lujan BJ, Tao W, et al. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci. 2011;52(5):2219–26. 10.1167/iovs.10-6479 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Stepien KE, Martinez WM, Dubis AM, Cooper RF, Dubra A, Carroll J. Subclinical photoreceptor disruption in response to severe head trauma. Arch Ophthalmol. 2012;130(3):400–2. 10.1001/archopthalmol.2011.1490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Genead MA, Fishman GA, Rha J, Dubis AM, Bonci DM, Dubra A, et al. Photoreceptor structure and function in patients with congenital achromatopsia. Invest Ophthalmol Vis Sci. 2011;52(10):7298–308. 10.1167/iovs.11-7762 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chen Y, Ratnam K, Sundquist SM, Lujan B, Ayyagari R, Gudiseva VH, et al. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2011;52(6):3281–92. 10.1167/iovs.10-6538 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Morgan JI, Han G, Klinman E, Maguire WM, Chung DC, Maguire AM, et al. High-resolution adaptive optics retinal imaging of cellular structure in choroideremia. Invest Ophthalmol Vis Sci. 2014;55(10):6381–97. 10.1167/iovs.13-13454 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Litts KM, Wang X, Clark ME, Owsley C, Freund KB, Curcio CA, et al. Exploring photoreceptor reflectivity through multimodal imaging of outer retinal tubulation in advanced age-related macular degeneration. Retina. 2016; epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Scoles D, Sulai YN, Langlo CS, Fishman GA, Curcio CA, Carroll J, et al. In vivo imaging of human cone photoreceptor inner segments. Invest Ophthalmol Vis Sci. 2014;55(7):4244–51. 10.1167/iovs.14-14542 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Dubis AM, Cooper RF, Aboshiha J, Langlo CS, Sundaram V, Liu B, et al. Genotype-dependent variability in residual cone structure in achromatopsia: Towards developing metrics for assessing cone health. Invest Ophthalmol Vis Sci. 2014;55(11):7303–11. 10.1167/iovs.14-14225 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Razeen MM, Cooper RF, Langlo CS, Goldberg MR, Wilk MA, Han DP, et al. Correlating photoreceptor mosaic structure to clinical findings in Stargardt disease. Transl Vis Sci Tech. 2016;5(2):6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Scoles D, Flatter JA, Cooper RF, Langlo CS, Robison S, Neitz M, et al. Assessing photoreceptor structure associated with ellipsoid zone disruptions visualized with optical coherence tomography. Retina. 2016;36(1):91–103. 10.1097/IAE.0000000000000618 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sun LW, Johnson RD, Langlo C, Cooper RF, Razeen MM, Russillo MC, et al. Assessing photoreceptor structure in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci. 2016;57(6):2428–42. 10.1167/iovs.15-18246 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Scoles D, Sulai Y, Cooper RF, Higgins BS, Johnson RD, Carroll J, et al. Photoreceptor inner segment morphology in Best Vitelliform Macular Dystrophy. Retina. 2016; epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet. 2014;383(9923):1129–37. 10.1016/S0140-6736(13)62117-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Edwards TL, Jolly JK, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, et al. Visual acuity after retinal gene therapy for choroideremia. N Engl J Med. 2016;374(20):1996–8. 10.1056/NEJMc1509501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wilk MA, McAllister JT, Cooper RF, Dubis AM, Patitucci TN, Summerfelt P, et al. Relationship between foveal cone specialization and pit morphology in albinism. Invest Ophthalmol Vis Sci. 2014;55(7):4186–98. 10.1167/iovs.13-13217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.DeLuca AM, Ephraim S, Scheetz TE, Stone E, Braun TA. Vision Variation Database (VVD). Invest Ophthalmol Vis Sci; 2013;54:E-abstract 3382. [Google Scholar]
- 38.Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557–63. 10.1002/humu.21438 [DOI] [PubMed] [Google Scholar]
- 39.Tanna H, Dubis AM, Ayub N, Tait DM, Rha J, Stepien KE, et al. Retinal imaging using commercial broadband optical coherence tomography. Br J Ophthalmol. 2010;94(3):372–6. 10.1136/bjo.2009.163501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Huang Y, Cideciyan AV, Papastergiou GI, Banin E, Semple-Rowland SL, Milam AH, et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39(12):2405–16. [PubMed] [Google Scholar]
- 41.McAllister JT, Dubis AM, Tait DM, Ostler S, Rha J, Stepien KE, et al. Arrested development: high-resolution imaging of foveal morphology in albinism. Vision Res. 2010;50(8):810–7. 10.1016/j.visres.2010.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Flatter JA, Cooper RF, Dubow MJ, Pinhas A, Singh RS, Kapur R, et al. Outer retinal structure after closed-globe blunt ocular trauma. Retina. 2014;34(10):2133–46. 10.1097/IAE.0000000000000169 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Cooper RF, Dubis AM, Pavaskar A, Rha J, Dubra A, Carroll J. Spatial and temporal variation of rod photoreceptor reflectance in the human retina. Biomed Opt Express. 2011;2(9):2577–89. 10.1364/BOE.2.002577 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Dubra A, Sulai Y. Reflective afocal broadband adaptive optics scanning ophthalmoscope. Biomed Opt Express. 2011;2(6):1757–68. 10.1364/BOE.2.001757 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Dubra A, Harvey Z. Registration of 2D images from fast scanning ophthalmic instruments In: Fischer B, Dawant B, Lorenz C, editors. Biomedical Image Registration. Lecture Notes in Computer Science. 1 ed. Berlin: Springer-Verlag; 2010. p. 60–71. [Google Scholar]
- 46.Packer O, Williams DR. Light, the Retinal Image, and Photoreceptors In: Shevell SK, editor. The Science of Color. 2nd ed. New York: OSA & Elsevier Science; 2003. p. 41–102. [Google Scholar]
- 47.Garrioch R, Langlo C, Dubis AM, Cooper RF, Dubra A, Carroll J. Repeatability of in vivo parafoveal cone density and spacing measurements. Optom Vis Sci. 2012;89(5):632–43. 10.1097/OPX.0b013e3182540562 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Cooper RF, Wilk MA, Tarima S, Carroll J. Evaluating descriptive metrics of the human cone mosaic. Invest Ophthalmol Vis Sci. 2016;57(7):2992–3001. 10.1167/iovs.16-19072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.McTaggart KE, Tran M, Mah DY, Lai SW, Nesslinger NJ, MacDonald IM. Mutational analysis of patients with the diagnosis of choroideremia. Hum Mutat. 2002;20(3):189–96. 10.1002/humu.10114 [DOI] [PubMed] [Google Scholar]
- 50.van den Hurk JA, van de Pol DJ, Wissinger B, van Driel MA, Hoefsloot LH, de Wijs IJ, et al. Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon. Hum Genet. 2003;113(3):268–75. 10.1007/s00439-003-0970-0 [DOI] [PubMed] [Google Scholar]
- 51.Tuten WS, Tiruveedhula P, Roorda A. Adaptive optics scanning laser ophthalmoscope-based microperimetry. Optom Vis Sci. 2012;89(5):563–74. 10.1097/OPX.0b013e3182512b98 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lujan BJ, Roorda A, Croskrey JA, Dubis AM, Cooper RF, Bayabo JK, et al. Directional Optical coherence tomography provides accurate outer nuclear layer and Henle fiber layer measurements. Retina. 2015;35(8):1511–20. 10.1097/IAE.0000000000000527 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.